BioSpace News Archive

Business

Ligand To Report Second Quarter 2023 Financial Results On August 8

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will report second quarter 2023 financial results after the close of the U.S. financial markets on Tuesday, August 8, 2023, and will hold a conference call at 4:30 p.m. Eastern Time that same day to discuss financial results and provide a general business update.

July 25, 2023
·
2 min read
Business

Vapotherm To Report Second Quarter 2023 Financial Results

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), today announced that it will release financial results for the second quarter of 2023 after the close of trading on Tuesday, August 8, 2023.

July 25, 2023
·
2 min read
Business

Bruker Announces Date and Time of Second Quarter 2023 Earnings Release and Webcast

Bruker Corporation announced it will report second quarter 2023 financial results before market opening on Thursday, August 3, 2023.

July 25, 2023
·
2 min read
Ever Heard of Keratoconus? Nearly 70% of Survey Respondents Answered “No” about the Sight-Threatening, Progressive Eye Disease

KC can lead to significant vision loss or even a corneal transplant; eye rubbing is a cause and symptom

July 25, 2023
·
2 min read
BioMidwest

Foundation for Sarcoidosis Research Awards Dr. Christen Vagts, University of Illinois Hospital and Clinic, Fellowship Grant for 2023–2025

The Foundation for Sarcoidosis Research is pleased to announce that the FSR Sarcoidosis Research Fellowship for 2023-2025 is being awarded to Dr. Christen Vagts from FSR Global Sarcoidosis Clinic Alliance Founding Member, University of Illinois Hospital and Clinic, for her outstanding proposal, Immune Mediators of Active Advanced Pulmonary Sarcoidosis.

July 25, 2023
·
3 min read
Pharm Country

Zynerba Pharmaceuticals Announces New Date for Reconvened Annual Meeting

Zynerba Pharmaceuticals, Inc. announced that the new date for the adjourned 2023 Annual Meeting of Stockholders is August 11, 2023 at 9:00 a.m. EDT.

July 25, 2023
·
4 min read
Biotech Bay

Impetus Grants Secures $10 million Commitment from Hevolution Foundation and Rosenkranz Foundation to Fund Aging Science

Impetus Grants, a nonprofit foundation dedicated to funding aging-related research that might otherwise be overlooked by traditional funding sources, announces a new round of matching funding.

July 25, 2023
·
2 min read
InnoCare Announces Approval of Clinical Trial of pan-TRK Inhibitor Zurletrectinib for the Treatment of Pediatric Patients in China

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Company has received approval to conduct clinical trial of its second generation pan-TRK inhibitor zurletrectinib (ICP-723) to treat pediatric patients (2 to 12 years old) in China.

July 25, 2023
·
1 min read
Business

Acrivon Therapeutics Announces the Appointment of Adam Levy, Ph.D., M.B.A., Experienced Biotech Investor Relations and Strategy Executive, to Senior Vice President and Head, Investor Relations and Corporate Affairs

Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV) today announced that Adam D. Levy, Ph.D., M.B.A., has joined Acrivon as senior vice president and head, investor relations and corporate affairs.

July 25, 2023
·
5 min read